NewsBenzinga울프 리서치, 테이샤 유전자 치료제 투자의견 ‘시장수익률 상회’로 분석 시작 울프 리서치, 테이샤 유전자 치료제 투자의견 ‘시장수익률 상회’로 분석 시작 Benzinga 2026.09.17 14:08 (GMT+0) Open on Benzinga Other news Exclusive | Nearly All Volume on FIFA-Linked Prediction Market Is Circular Trading RenaissanceRe: I’m Taking Advantage Of 7.38% Yielding Preferred Stock (NYSE:RNR) AeroVironment: The Crash Made It Fair, Not Cheap (NASDAQ:AVAV) Here’s Why Cathie Wood Just Bet $12.1M on Archer Aviation Stock Solana Ad Lasted 10 Minutes in China. Critics Blamed CZ FMC Stock Tumbles to Multi-Year Lows After Earnings Shocker. It Looks Worth the Risk Here
